Search research articles
Contact Us
Filters
Showing results (11-20 of 32) with videos related to
Page
of 4
Sort By:
Pediatric Blood & Cancer
|
July 14, 2023
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma
Nader Kim El-Mallawany, Sarah Alexander, Mark Fluchel, et al.
Current Problems in Cancer
|
March 7, 2025
The outcomes of pediatric extracranial malignant germ cell tumors: A decade of experience from a single institution in Southern Vietnam
An Thi Thanh Dao, Nhi Thuy To, Chau Hoan Nguyen, et al.
Cancer Reports (Hoboken, N.J.)
|
November 7, 2023
Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patients
Savannah S Shumock, William C Temple, Amanda Marinoff, et al.
Pediatric Blood & Cancer
|
January 9, 2025
Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies
Amanda E Marinoff, Allyson Thrall, Kathryn Aaronson, et al.
Orphanet Journal of Rare Diseases
|
April 26, 2025
Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH)
Leonard Naymagon, Philip Roehrs, Michelle Hermiston, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2023
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies
William C Temple, Matthew A Nix, Akul Naik, et al.
Science Translational Medicine
|
September 16, 2011
Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response
Xiaoyin Wang, Junya Takagawa, Viola C Lam, et al.
Oncoimmunology
|
December 15, 2018
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model
Yaya Chu, Sanghoon Lee, Tishi Shah, et al.
The Oncologist
|
July 13, 2023
Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center
Bridget P Keenan, Amanda Sibley, Li Zhang, et al.
Eclinicalmedicine
|
November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns
Valentin Barsan, Yimei Li, Snehit Prabhu, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 32) with videos related to
Sort By:
Page
of 4
Pediatric Blood & Cancer
|
July 14, 2023
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma
Nader Kim El-Mallawany, Sarah Alexander, Mark Fluchel, et al.
Current Problems in Cancer
|
March 7, 2025
The outcomes of pediatric extracranial malignant germ cell tumors: A decade of experience from a single institution in Southern Vietnam
An Thi Thanh Dao, Nhi Thuy To, Chau Hoan Nguyen, et al.
Cancer Reports (Hoboken, N.J.)
|
November 7, 2023
Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patients
Savannah S Shumock, William C Temple, Amanda Marinoff, et al.
Pediatric Blood & Cancer
|
January 9, 2025
Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic Malignancies
Amanda E Marinoff, Allyson Thrall, Kathryn Aaronson, et al.
Orphanet Journal of Rare Diseases
|
April 26, 2025
Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH)
Leonard Naymagon, Philip Roehrs, Michelle Hermiston, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2023
Framework humanization optimizes potency of anti-CD72 nanobody CAR-T cells for B-cell malignancies
William C Temple, Matthew A Nix, Akul Naik, et al.
Science Translational Medicine
|
September 16, 2011
Donor myocardial infarction impairs the therapeutic potential of bone marrow cells by an interleukin-1-mediated inflammatory response
Xiaoyin Wang, Junya Takagawa, Viola C Lam, et al.
Oncoimmunology
|
December 15, 2018
Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,<i>in-vitro</i> proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model
Yaya Chu, Sanghoon Lee, Tishi Shah, et al.
The Oncologist
|
July 13, 2023
Evaluation of Culture Conducive to Academic Success by Gender at a Comprehensive Cancer Center
Bridget P Keenan, Amanda Sibley, Li Zhang, et al.
Eclinicalmedicine
|
November 13, 2023
Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns
Valentin Barsan, Yimei Li, Snehit Prabhu, et al.
Page
of 4